At what enterprise value was IMAPOLE acquired in 2022?

During the acquisition of IMAPOLE by EURAZEO in 2022, the transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR.

What was the EV/EBITDA of IMAPOLE when it was acquired by EURAZEO?

The estimated EV/EBITDA multiple for IMAPOLE is in the range of 15x - 25x.

When was IMAPOLE acquired by EURAZEO?

IMAPOLE was acquired by EURAZEO in 2022.

What was the revenue of IMAPOLE at the time of the deal?

The revenue of IMAPOLE at the time of the deal is estimated to be in the range of 5M - 25M EUR.

What was the EBITDA of IMAPOLE during the acquisition?

IMAPOLE's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the IMAPOLE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the IMAPOLE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://fr.newsroom.eurazeo.com/actualites/le-fonds-nov-sante-actions-non-cotees-investit-dans-imapole-69f34-7ed35.html

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaIMAPOLE

09/2022

IMAPOLE acquired by EURAZEO

FRANCE Health Providers / Outpatient Care / Radiology EV 100M - 350M EUR

Context

Eurazeo has partnered with Bpifrance to complete a major investment of over EUR 50 million in Imapole. This investment marks a strategic turning point in the professionalization of regional medical imaging groups in France. The strategic rationale for this transaction centers on a "platform-build" play, merging the group’s practitioner-led operational depth with the sponsors' extensive expertise in healthcare scaling and digital transformation. This structural alignment provides the organization with the institutional capital and strategic hardware required to address the high demand for imaging capacity in under-served areas.

IMAPOLE, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Based in Lyon, ImaOne is a prominent medical imaging group. The organization is managed and owned by a group of associate radiologists, providing essential diagnostic services to the regional healthcare ecosystem. As an independent player in the medical imaging sector, the group focuses on maintaining high standards of clinical excellence while navigating the evolving regulatory landscape for medical practices in France. Its operational model relies on the expertise of its medical associates to deliver specialized imaging services, ranging from standard diagnostics to advanced medical screenings.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
11/2022	RADNET	HEART & LUNG IMAGING	UNITED KINGDOM	Radiology
10/2022	CBPE CAPITAL	VEINCENTRE	UNITED KINGDOM	Aesthetic & Cosmetic Clinics
09/2022	ORADIANSE	REVEL	FRANCE	Radiology
08/2022	FREEMAN SPOGLI	EVERVET PARTNERS	UNITED STATES	Vet Clinics
07/2022	LATOUR CAPITAL	PHARMACIE LAFAYETTE - GROUPE HYGIE31	FRANCE	Pharmacy
07/2022	INFRAVIA CAPITAL	UNIVET	FRANCE	Vet Clinics
07/2022	ANDERA PARTNERS	GROUPE RESONANCE IMAGERIE	FRANCE	Radiology
06/2022	TRITON PARTNERS	ESPERI CARE	FINLAND	Nursing Homes
06/2022	EURAZEO	SEVETYS	FRANCE	Vet Clinics
06/2022	ARDIAN	SIMAGO	FRANCE	Radiology

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 5M - 25M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMAPOLE by EURAZEO are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: eurazeo